ANXV
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ANXV, covering 2024-12-11 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion [Phase 2]